![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Tato, Maia; Kumar, Santhosh V.; Liu, Yajuan; Mulay, Shrikant R.; Moll, Solange; Popper, Bastian; Eberhard, Jonathan N.; Thomasova, Dana; Rufer, Arne Christian; Gruner, Sabine; Haap, Wolfgang; Hartmann, Guido und Anders, Hans-Joachim
(2017):
Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury.
In: Scientific Reports, Bd. 7, 2775
[PDF, 3MB]
Kumar, Santhosh V. R.; Darisipudi, Murthy N.; Steiger, Stefanie; Devarapu, Satish Kumar; Tato, Maia; Kukarni, Onkar P.; Mulay, Shrikant R.; Thomasova, Dana; Popper, Bastian; Demleitner, Jana; Zuchtriegel, Gabriele; Reichel, Christoph; Cohen, Clemens D.; Lindenmeyer, Maja T.; Liapis, Helen; Moll, Solange; Reid, Emma; Stitt, Alan W.; Schott, Brigitte; Gruner, Sabine; Haap, Wolfgang; Ebeling, Martin; Hartmann, Guido und Anders, Hans-Joachim
(2016):
Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.
In: Journal of the American Society of Nephrology, Bd. 27, Nr. 6: S. 1635-1649
Rupanagudi, Khader Valli; Kulkarni, Onkar P.; Lichtnekert, Julia; Darisipudi, Murthy Narayana; Mulay, Shrikant R.; Schott, Brigitte; Gruner, Sabine; Haap, Wolfgang; Hartmann, Guido und Anders, Hans-Joachim
(2015):
Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming.
In: Annals of the Rheumatic Diseases, Bd. 74, Nr. 2: S. 452-463
[PDF, 20MB]